The role of APOBEC3B in the development of hepatocellular carcinoma should be investigated with the consideration of hepatitis B virus evolution

References

[1] Sia D,Friedman SL.Liver cancer cell of origin,molecular class, and effects on patient prognosis..Gastroenterology2017;152:745-61

[2] Yang F,Yang Y,Zhao J.Contribution of Hepatitis B Virus Infection to the Aggressiveness of Primary Liver Cancer: A Clinical Epidemiological Study in Eastern China..Front Oncol2019;21;9:370 PMCID:PMC6537574

[3] Bertuccio P,Carioli G,La Vecchia C.Global trends and predictions in hepatocellular carcinoma mortality..J Hepatol2017;302-9

[4] Liu W,Du Y.Cancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesis..Curr Oncol2016;23:e49-56 PMCID:PMC4754069

[5] Deng Y,Zhang Q,Cao G.Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma..Cancer Lett2014;343:161-71

[6] Cao G.Cancer Evo-Dev, a novel hypothesis derived from studies on hepatitis B virus-induced carcinogenesis..Hepatoma Res2017;3:241-59

[7] Roberts SA,Klimczak LJ,Fargo D.An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers..Nat Genet2013;45:970-6 PMCID:PMC3789062

[8] Wang D,Li J,Zhao S.APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression..Gut2019;Epub ahead of print. doi: 10.1136/gutjnl-2018-317601

[9] Lucifora J,Reisinger F,Stadler D.Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA..Science2014;343:1221-8 PMCID:PMC6309542

[10] Liu W,Yang F,Ni C.Genetic polymorphisms predisposing the interleukin-6-induced APOBEC3B-UNG imbalance increase HCC risk via promoting the generation of APOBEC-signature HBV mutations..Clin Cancer Res2019;

[11] Alexandrov LB,Wedge DC,Behjati S.Signatures of mutational processes in human cancer..Nature2013;500:415-21 PMCID:PMC3776390